In this line, to shed light on the subclonal architecture of FLT3-ITDmut AML and to track FLT3-ITDmut and other clones, we characterized the molecular profile of CD34/CD123/CD25/CD99+ enriched LPCs. This evidence concerns the gene CD99 and acute myeloid leukemia.